-+ 0.00%
-+ 0.00%
-+ 0.00%

Hwail Pharm Delays Controlling Stake Transfer to Dec. 17

PUBT·11/18/2026 07:15:11
Listen to the news
Hwail Pharm Delays Controlling Stake Transfer to Dec. 17
  • Hwail Pharm postponed the KRW 55 billion final share-sale payment to Dec. 17 from Nov. 19, 2026, under an amended agreement.
  • The largest-shareholder change to Pharma & Bio New Technology Partnership is now scheduled for Dec. 17.
  • The buyer will acquire 2,343,750 common shares, representing a 27.84% stake.
  • The transaction totals KRW 75 billion at KRW 32,000 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hwail Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261118900309), on November 18, 2026, and is solely responsible for the information contained therein.